Table 1 Distribution of the clinico-pathological factors of the study participants.

From: Factors affecting health-related quality of life following axillary lymph node dissection among breast cancer survivors in Egypt

Characteristics

Frequency (%)

Time since diagnosis (months)

 Median (IQR)

48 (24–84)

 Minimum - maximum

(12–180)

Type of Surgery

 MRM

79 (52.7)

 BCS

71 (47.3)

Laterality

Right

84 (56.0)

Left

66 (44.0)

Histological type

IDC

130 (86.7)

ILC

20 (13.3)

Histological grade

I

3 (2.0)

II

128 (85.3)

III

19 (12.7)

ER

Positive

129 (86.0)

Negative

21 (14.0)

PR

Positive

116 (77.3)

Negative

34 (22.7)

HER2

Positive

28 (18.7)

Negative

122 (81.3)

Lymph Node status

Positive

89 (59.3)

Negative

61 (40.7)

Total number of disected LN

≤10

65 (43.3)

> 10

85 (56.7)

Subtype

HR+/HER2

108 (72.0)

HR+/HER+

22 (14.7)

HR/HER+

6 (4.0)

HR/HER

14 (9.3)

AJCC Stage

Stage I

11 (7.3)

Stage II

97 (64.7)

Stage III

42 (28.0)

Type of Adjuvant Therapy

Chemotherapy

86 (59.3)

Radiotherapy

89 (59.3)

Hormonal Therapy

119 (79.3)

Targeted Therapy

24 (16.0)